A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
Current influenza vaccines have a reduced efficacy in the elderly. This study will investigate the immunogenicity, safety and tolerability of an adjuvanted influenza vaccine in elderly participants.
Epistemonikos ID: 507cc75813894b1203485891fefc76e8decd6886
First added on: May 04, 2024